According to the FDA, nine ophthalmology drugs are in short supply.
They are:
1. Azithromycin (AzaSite) ophthalmic solution 1%
2, Cyclopentolate ophthalmic solution
3. Dexamethasone sodium phosphate injection
4. Echothiophate iodide (phospholine iodide) ophthalmic solution
5. Erythromycin ophthalmic ointment
6. Fluorescein Injection
7. Hydroxypropyl (Lacrisert) cellulose ophthalmic insert
8. Teprotumumab-trbw
9. Triamcinolone acetonide injectable suspension
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
